Z5. COVID-19 Complications, co-infections, and clinical outcomes
Poster Session: COVID-19: Complications, Coinfections and Clinical Outcomes
Thomas F. Oppelt, PharmD, BCPS
Sr. Director, Medical Affairs
Gilead Sciences, Inc
Foster City, California, United States
Michael Caron, PharmD
Gilead Sciences, Inc.
Foster City, California, United States
Jamie Zagorski, MSN, FNP
Gilead Sciences, Inc.
Foster City, California, United States
Rodney H. Taylor, PharmD
Gilead Sciences, Inc.
Foster City, California, United States
Chinonso Akano, PharmD
Gilead Sciences, Inc.
Foster City, California, United States
Lisa McCorkell, MPP
Patient-Led Research Collaborative
Oakland, California, United States
LaKeisha Williams, PharmD, MSPH
Center for Minority Health and Health Disparities Research and Education, Xavier University of Louisiana
New Orleans, Louisiana, United States
Gary A. Puckrein, PhD
National Minority Quality Forum
Washington, District of Columbia, United States